Polar Capital Holdings’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$256M	Buy	4,405,312 +1,939,618	+79%	+$89.4M	1.12%	30
2025 Q4	$111M	Sell	2,465,694 -81,072	-3%	-$3.4M	0.51%	63
2025 Q3	$102M	Sell	2,546,766 -156,490	-6%	-$5.51M	0.49%	58
2025 Q2	$84.6M	Buy	2,703,256 +80,217	+3%	+$2.62M	0.44%	61
2025 Q1	$88M	Sell	2,623,039 -74,618	-3%	-$2.83M	0.54%	50
2024 Q4	$106M	Buy	2,697,657 +253,012	+10%	+$10.5M	0.59%	47
2024 Q3	$96.2M	Sell	2,444,645 -91,413	-4%	-$3.69M	0.46%	50
2024 Q2	$98.9M	Sell	2,536,058 -76,050	-3%	-$3.04M	0.58%	45
2024 Q1	$112M	Sell	2,612,108 -454,520	-15%	-$20.9M	0.59%	42
2023 Q4	$141M	Buy	3,066,628 +62,881	+2%	+$2.22M	0.87%	21
2023 Q3	$103M	Sell	3,003,747 -18,324	-0.6%	-$685K	0.76%	34
2023 Q2	$116M	Buy	3,022,071 +5,253	+0.2%	+$209K	0.8%	33
2023 Q1	$108M	Sell	3,016,818 -29,056	-1%	-$1.07M	0.79%	36
2022 Q4	$120M	Buy	3,045,874 +383,152	+14%	+$14M	0.96%	22
2022 Q3	$96.1K	Buy	2,662,722 +122,663	+5%	+$4.41M	0.61%	40
2022 Q2	$77.3K	Buy	2,540,059 +350,000	+16%	+$10.6M	0.45%	54
2022 Q1	$67K	Buy	2,190,059 +502,015	+30%	+$15M	0.31%	81
2021 Q4	$52.7K	Buy	+1,688,044	New	+$50.4M	0.21%	100